These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 6461466

  • 21. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
    Sato M, Zeng GQ, Rowley E, Turner CH.
    Endocrinology; 1998 Nov; 139(11):4642-51. PubMed ID: 9794476
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Intermittent administration of human parathyroid hormone (1-34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur.
    Tao ZS, Zhou WS, Qiang Z, Tu KK, Huang ZL, Xu HM, Sun T, Lv YX, Cui W, Yang L.
    J Biomater Appl; 2016 Feb; 30(7):952-60. PubMed ID: 26482573
    [Abstract] [Full Text] [Related]

  • 24. Protein malnutrition attenuates bone anabolic response to PTH in female rats.
    Ammann P, Zacchetti G, Gasser JA, Lavet C, Rizzoli R.
    Endocrinology; 2015 Feb; 156(2):419-28. PubMed ID: 25396268
    [Abstract] [Full Text] [Related]

  • 25. Effects of combined human parathyroid hormone (1-34) and menaquinone-4 treatment on the interface of hydroxyapatite-coated titanium implants in the femur of osteoporotic rats.
    Li H, Zhou Q, Bai BL, Weng SJ, Wu ZY, Xie ZJ, Feng ZH, Cheng L, Boodhun V, Yang L.
    J Bone Miner Metab; 2018 Nov; 36(6):691-699. PubMed ID: 29280077
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [Abstract] [Full Text] [Related]

  • 28. Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone.
    Kirby BJ, Ma Y, Martin HM, Buckle Favaro KL, Karaplis AC, Kovacs CS.
    J Bone Miner Res; 2013 Sep; 28(9):1987-2000. PubMed ID: 23505097
    [Abstract] [Full Text] [Related]

  • 29. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
    Reeve J, Davies UM, Hesp R, McNally E, Katz D.
    BMJ; 1990 Aug 11; 301(6747):314-8. PubMed ID: 2393738
    [Abstract] [Full Text] [Related]

  • 30. Calcium deficiency in fluoride-treated osteoporotic patients despite calcium supplementation.
    Dure-Smith BA, Farley SM, Linkhart SG, Farley JR, Baylink DJ.
    J Clin Endocrinol Metab; 1996 Jan 11; 81(1):269-75. PubMed ID: 8550763
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment.
    Sato M, Ma YL, Hock JM, Westmore MS, Vahle J, Villanueva A, Turner CH.
    J Pharmacol Exp Ther; 2002 Jul 11; 302(1):304-13. PubMed ID: 12065731
    [Abstract] [Full Text] [Related]

  • 33. Effects of growth hormone in osteoporosis.
    Aloia JF, Zanzi I, Ellis K, Jowsey J, Roginsky M, Wallach S, Cohn SH.
    J Clin Endocrinol Metab; 1976 Nov 11; 43(5):992-9. PubMed ID: 993324
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.
    Yang Y, Aghazadeh-Habashi A, Panahifar A, Wu Y, Bhandari KH, Doschak MR.
    Drug Deliv Transl Res; 2017 Aug 11; 7(4):482-496. PubMed ID: 28721611
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women.
    Tsai KS, Ebeling PR, Riggs BL.
    J Clin Endocrinol Metab; 1989 Nov 11; 69(5):1024-7. PubMed ID: 2793989
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.